SYMBICORT Inhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYMBICORT Inhaler, covering 2016-09-15 to 2016-09-15. Get the full timeline:
Most recent: Clinical Trial Update: CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. [Phase 4]